论文部分内容阅读
我国首次研制成功一种供肝类疾病患者静脉滴注的复方中药苦黄注射液,并经卫生部批准作为中药二类新药在江苏常熟制药厂投入生产。 苦黄注射液是由常熟制药厂和江苏省人民医院联合攻关,并与全国20多家科研医疗单位协作研制
For the first time, China successfully developed a compound traditional Chinese medicine bitter yellow injection for intravenous injection of liver diseases, and was approved by the Ministry of Health as a second class of new Chinese medicines to be put into production at the Changshu Pharmaceutical Factory in Jiangsu Province. Bitter yellow injection was jointly researched by Changshu Pharmaceutical Factory and Jiangsu Provincial People’s Hospital, and it was developed in collaboration with more than 20 scientific research and medical institutions across the country.